Stories by aaavl2821

Gene therapy for SMA could be cost-effective at price of $1-1.5M [pdf]

After another anti-amyloid failure, drugmakers throw more good money after bad

Are startups 10x better at R&D than big pharma?

Potent Weed Linked to Psychosis

Ask HN: Medium requiring signup to view articles?

Show HN: Find potential investors for biotherapeutics startups

Deerfield ponies up $100M for translational research deal with Harvard

Beginner programming project: interactive blog

Top drugs and companies by sales 2018

A majority of AI studies don't adequate validate methods

Roche fought through a bidding war for $4.8B gene therapy buyout

Why Most Published Research Findings Are False (2005)

John Ioannidis Aims His Bazooka at Nutrition Science (2018)

The steady growth in health care jobs isn’t all positive

How to review a science paper

The day you became a better writer (2007)

Early-stage biotech VC Atlas Venture's 2018 year in review

JNJ buys robotic surgery company for up to $5.75B

The Clinic Giveth and Most Definitely Taketh Away

Pricing pressure a hard pill for pharma industry to swallow

4 5 6 7 8 9 10 11 12 13